 |
인쇄하기
취소
|
KFDA approved Il Yang's ilaprazole phase III study
Il Yang announced on Sept. 28 that Ilaprozole, an anti-peptic ulcer drug, obtained the KFDA approval on its phase III study for the treatment of duodenal and stomach ulcer, conducting at 15 university hospitals for one year including SNU hospital.
The company said that up to now they spent about 25 billion won for its development and the phase III studies would be performed in the United St...
The company said that up to now they spent about 25 billion won for its development and the phase III studies would be performed in the United St...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.